Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ligand Pharmaceuticals Inc (LGND)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Dorset Management

David M. Knott

798,100 $108,661 -21% 46.44%
2.
HealthInvest Partners AB

Anders Hallberg And Carl Bennet

47,900 $6,522 -15% 7.61%
3.
Cardinal Capital

Amy Minella

623,341 $84,868 -23% 3.5%
4.
CQS Cayman LPBOND

Michael Hintze

26,000,000 $47,421 +4% 3.18%
5.
Angelo Gordon & CoBOND

John M. Angelo And Michael L. Gordon

13,500,000 $24,629 +59% 1.14%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaning Holdings Date Form 4
$45.23 126 Officer 27,433 2014-12-31 Filing
$45.23 46 Officer 55,016 2014-12-31 Filing
$45.23 103 Officer 2,831 2014-12-31 Filing
$45.68 2,000 Director 49,286 2014-10-15 Filing
$44.91 85 Officer 53,970 2014-10-10 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$140.22 24,400 Director 90,251 2017-11-17 Filing
$140.34 2,258 Officer, Director 141,284 2017-11-17 Filing
$139.79 4,000 Director 20,956 2017-11-17 Filing
$141.71 5,000 Director 35,649 2017-11-16 Filing
$142.63 6,559 Officer 8,147 2017-11-17 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 16,000,000 $29,198 4.74%
2. 13,403,000 $24,490 3.03%
3. 132,537 $18,045 2.9%
4. 22,046 $3,002 2.75%
5. 63,346 $8,625 2.73%
News See All